Navigation Links
Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia
Date:6/29/2009

linical results for VA106483 are very encouraging and we look forward to advancing it into the next stages of clinical development. These results will also further highlight the value of this new drug candidate as we progress partnership discussions in parallel. '

Notes to Editors:

About Vantia Therapeutics

Vantia Therapeutics is an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets. Formed in 2008 as a spin-out of Ferring Research Ltd's small molecule R&D, it has two clinical phase products, VA106483 for the treatment of nocturia in BPH patients and VA111913 for the treatment of dysmenorrhoea, as well as preclinical and discovery programmes based on protease inhibition with potential in the areas of oncology and inflammation. The company's investors include MVM Life Science Partners, SV Life Sciences and Novo A/S. Vantia Therapeutics is situated on Southampton Science Park, UK, where it occupies 10,000 sq ft of chemistry and biology facilities. For further information, please go to http://www.vantiatherapeutics.com.

About nocturia

Nocturia (defined as waking to void at night) is a common condition, with prevalence increasing markedly with age. It is often the presenting symptom of benign prostatic hypertrophy (BPH) with at least 70% of BPH patients complaining of nocturia. Whilst some symptoms of BPH are successfully addressed by the standard BPH therapies of alpha blockers and 5-alpha reductase inhibitors, nocturia remains inadequately treated. With estimates putting the number of BPH/nocturia sufferers at 55 million in the seven largest markets world wide, and only 10% of these believed to be receiving any kind of treatment, it is a clear area of unmet medical need estimated to be worth in excess of $500m. The hormone vasopressin is involved in
'/>"/>

SOURCE Vantia Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vantia Therapeutics Pipeline Continues to Mature
2. Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
3. Horizon Therapeutics HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain
4. InteKrin Therapeutics to Present at the 2009 American Diabetes Association Annual Meeting
5. Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support
6. Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting
7. Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies
8. FDA Accepts Arno Therapeutics IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
9. Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
10. Arcion Therapeutics Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy
11. Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... -- Decision Resources, one of the world,s leading ... issues, finds that an overall survival benefit would ... surveyed European oncologists in their decision to prescribe ... treatment of breast cancer. ,, The new Special ... European Trends in Targeted Therapies in Breast Cancer: ...
(Date:12/15/2009)... Accumetrics, Inc., developer and marketer of the VerifyNow® ... for measuring an individual,s response to multiple antiplatelet ... the number of international and U.S. distribution agreements, ... significant capital financing that will take the company ... continued its commitment to creating a powerful, worldwide ...
(Date:12/14/2009)... LONDON, Dec. 14 The 2009 Frost ... the Ultrasound Market is conferred on SonoScape. The ... - the need for special features, pricing, and ... (HCU). The performance of this high-end colour ... high-end, cart-based echo ultrasound system. ,, ...
Breaking Medicine Technology:For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 2For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 3Accumetrics Closes 2009 with Positive Outlook 2Accumetrics Closes 2009 with Positive Outlook 3Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8 2Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8 3MDS Reports Second Quarter 2009 Financial Results 48568 1MDS Reports Second Quarter 2009 Financial Results 48568 2MDS Reports Second Quarter 2009 Financial Results 48568 3MDS Reports Second Quarter 2009 Financial Results 48568 4MDS Reports Second Quarter 2009 Financial Results 48568 5MDS Reports Second Quarter 2009 Financial Results 48568 6MDS Reports Second Quarter 2009 Financial Results 48568 7MDS Reports Second Quarter 2009 Financial Results 48568 8MDS Reports Second Quarter 2009 Financial Results 48568 9MDS Reports Second Quarter 2009 Financial Results 48568 10MDS Reports Second Quarter 2009 Financial Results 48568 11MDS Reports Second Quarter 2009 Financial Results 48568 12MDS Reports Second Quarter 2009 Financial Results 48568 13MDS Reports Second Quarter 2009 Financial Results 48568 14MDS Reports Second Quarter 2009 Financial Results 48568 15MDS Reports Second Quarter 2009 Financial Results 48568 16MDS Reports Second Quarter 2009 Financial Results 48568 17MDS Reports Second Quarter 2009 Financial Results 48568 18MDS Reports Second Quarter 2009 Financial Results 48568 19Isis Pharmaceuticals to Present at Jefferies 3rd Annual Healthcare Conference 48563 1Australia 3A Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight 12575 1Australia 3A Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight 12575 2Australia 3A Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight 12575 3Australia 3A Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight 12575 4
... Cell Therapeutics, Inc. (CTI),(Nasdaq and MTA: ... for the,Zevalin(R) ([90Y]-ibritumomab tiuxetan) First-line Indolent (FIT) ... (ASH) 50th Annual Meeting by,Morschhauser, et al ... following Zevalin consolidation therapy for patients with,follicular ...
... SAN FRANCISCO, Dec. 7 The largest study ever ... help prevent deadly blood clots in patients with cancer ... on Sunday, December 7, at 9:30 a.m., during the ... in San Francisco, CA. Additional research being featured at ...
Other Medicine Technology:Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 2Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 3Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 4Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 5Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 2Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 3Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 4Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 5Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 6Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 7Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 8Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 9
(Date:12/15/2009)... Seattle’s premier organic meal delivery service ( www.delicious-planet.com ) is ... Detox Program, Randi Carter, company founder and CEO reported today. ... ... – Seattle, WA) – Delicious Planet, Seattle’s premier organic meal ... the launch of its Delicious Planet Detox Program, Randi Carter, ...
(Date:12/15/2009)... Dec. 15 Comcast Corporation and Stand Up ... first-ever video-on-demand (VOD) initiative Stand Up 2 Cancer ... funds for innovative cancer research. Debuting exclusively on ... On Demand will feature an extraordinary library of ... of the world,s biggest stars and groups. ...
(Date:12/15/2009)... At a time when Americans spend over $50 billion ... Raymond Hall is theorizing a painful connection between conventional ... called Pillo1 ( www.pillo1.com ) to address the problem. ... John,s Medical Plaza Sleep Disorders Center showed that Pillo1 ... position and promotes increased time spent in REM (rapid ...
(Date:12/15/2009)... enable clean transition to new coding system. , ... ... 2009 -- The American Academy of Professional Coders ( AAPC ... training for health plans across the country beginning January. Developed ... coding and reimbursement experts, the on-site trainings are designed to ...
(Date:12/15/2009)... for consultations how will they get paid for patient care? ... terms. , ... Washington, DC (Vocus) ... eliminate consultation codes. These codes are what healthcare providers ... for a medical consultation, whether in a provider’s office or ...
Breaking Medicine News(10 mins):Health News:Delicious Planet Organic Meal Service Is Accepting Orders For Its Weekly Detox Program Delivery 2Health News:Delicious Planet Organic Meal Service Is Accepting Orders For Its Weekly Detox Program Delivery 3Health News:Delicious Planet Organic Meal Service Is Accepting Orders For Its Weekly Detox Program Delivery 4Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 2Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 3Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 4Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 5Health News:Sleep Study Shows Pillo1 Re-Educates Body to Naturally Move Into Optimal Sleep Position and Increases REM Sleep by 21.3% 2Health News:AAPC Now Offers On-site ICD-10 Training for Health Plans Nationwide 2Health News:AAPC Now Offers On-site ICD-10 Training for Health Plans Nationwide 3Health News:Medicare Eliminates Consultation Codes for Doctors 2
... study conducted by David Flora, PhD of the University of ... Chassin, PhD of Arizona State University//, says that parental alcoholism ... is generally known that children of alcoholics (COA's) suffer because ... time that a correlation has been established between alcohol abuse ...
... Palmer and his team from Southampton General Hospital, studied ... The research work is aimed at studying the environmental ... exposure to metal fume. ,Researchers found that ... low compared to the normal persons and an absence ...
... in serious trouble with regard to a trip made to ... halt, an eight-year-old health program for meant for the country’s ... Vision that operates the Nayab Health Services project for masseurs ... ,Helped by Britain's Naz Foundation International, Vision began a drop-in ...
... self-esteem and health of people, according to Penn State researchers. ... when compared to those who are happily married. Over a ... unhappy // marriages were interviewed. , ... studies, and demography said that dissolving a unhappy marriage would ...
... earlier research which said that fish was capable of scaling ... are present in fish do not serve to reduce cancer ... has however been // witnessed in the case of people ... ,Several trials have attempted to assess the effects of ...
... have proposed the administration of flu vaccine to all children ... to prevent the incidence of seasonal flu. The dreadful condition, ... winter, had claimed the valuable lives of over 1000 UK ... and Immunisation that addresses important medical issues and provides related ...
Other Medicine News:Health News:Pakistani Gays Land Themselves In Trouble 2
... These revised charts incorporate the slight change ... the 10 Sloan letters derived from the ... eyes during the ETDRS study. The original ... examination of 234 eyes. In addition to ...
Created to simplify stereopsis screening in children. Based on principles of random dots. No glasses are necessary for this stereo test, and the child's eye movement can be easily observed....
... Stereo Cube is used to diagnose Stereo and ... use of polarized glasses. The test can ... stereopsis, visual attention, form and depth perception. The ... to 450 seconds of arc and is ideal ...
... simplify stereopsis screening in children. It is based ... Lang Stereotest II measures disparities: Moon and Star ... of arc plus monocularly visible star. In the ... smaller and less dense. This disparity is finer, ...
Medicine Products: